We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.
- Authors
Yongyue Wei; Tejera, Paula; Zhaoxi Wang; Ruyang Zhang; Feng Chen; Li Su; Xihong Lin; Bajwa, Ednan K.; Thompson, B. Taylor; Christiani, David C.; Wei, Yongyue; Wang, Zhaoxi; Zhang, Ruyang; Chen, Feng; Su, Li; Lin, Xihong
- Abstract
<bold>Rationale: </bold>Platelets are believed to contribute to acute respiratory distress syndrome (ARDS) pathogenesis through inflammatory coagulation pathways. We recently reported that leucine-rich repeat-containing 16A (LRRC16A) modulates baseline platelet counts to mediate ARDS risk.<bold>Objectives: </bold>To examine the role of LRRC16A in ARDS survival and its mediating effect through platelets.<bold>Methods: </bold>A total of 414 cases with ARDS from intensive care units (ICUs) were recruited who had exome-wide genotyping data, detailed platelet counts, and follow-up data during ICU hospitalization. Association of LRRC16A single-nucleotide polymorphisms (SNPs) and ARDS prognosis, and the mediating effect of SNPs through platelet counts were analyzed. LRRC16A mRNA expression levels for 39 cases with ARDS were also evaluated.<bold>Measurements and Main Results: </bold>Missense SNP rs9358856G>A within LRRC16A was associated with favorable survival within 28 days (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.38-0.87; P = 0.0084) and 60 days (P = 0.0021) after ICU admission. Patients with ARDS who carried the variant genotype versus the wild-type genotype showed an attenuated platelet count decline (∆PLT) within 28 days (difference of ∆PLT, -27.8; P = 0.025) after ICU admission. Patients with ∆PLT were associated with favorable ARDS outcomes. Mediation analysis indicated that the SNP prognostic effect was mediated through ∆PLT within 28 days (28-day survival: HRIndirect, 0.937; 95% CI, 0.918-0.957; P = 0.0009, 11.53% effects mediated; 60-day survival: HRIndirect, 0.919; 95% CI, 0.901-0.936; P = 0.0001, 14.35% effects mediated). Functional exploration suggested that this SNP reduced LRRC16A expression at ICU admission, which was associated with a lesser ∆PLT during ICU hospitalization.<bold>Conclusions: </bold>LRRC16A appears to mediate ∆PLT after ICU admission to affect the prognosis in patients with ARDS.
- Publication
American Journal of Respiratory & Critical Care Medicine, 2017, Vol 195, Issue 10, p1353
- ISSN
1073-449X
- Publication type
journal article
- DOI
10.1164/rccm.201605-0946OC